Screening of serologically negative plasma pools for hepatitis C virus by nucleic acid amplification testing in Croatia, 2001-2003

Transfusion and Apheresis Science

Volumn 33, Issue 2, 2005, Pages 175-179

  Forčić, Dubravko ^a   Zgorelec, Renata ^a   Košutić Gulija, Tanja ^a   Ivančić, Jelena ^a   Baričević, Marijana ^a   Lupret, Ljerka ^a   Mažuran, Renata ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

HCV RNA; NAT; Plasma pools

Indexed keywords

RNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; CROATIA; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INCIDENCE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; RNA ANALYSIS; SEROLOGY; VIRUS INFECTION; VIRUS TRANSMISSION;

BLOOD DONORS; CAPSID PROTEINS; CROATIA; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 24944486700     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.07.003     Document Type: Article

References (19)

1. D.R. Taylor Hepatitis C virus: evasion of the interferon-induced antiviral response J Mol Med 78 2000 182 190
2. J.H. Han, V. Shyamala, K.H. Richman, M.J. Brauer, B. Irvine, and M.S. Urdae Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly (A) tails at the 3′ end Proc Natl Acad Sci USA 88 1991 1711 1715
3. M.E. Major, and S.M. Feinstone The molecular virology of hepatitis C Hepatology 25 1997 1527 1538
4. A.M. Di Bisceglie Hepatitis C Lancet 351 1998 351 355
5. M. Alter Epidemiology of hepatitis C Hepatology 26 Suppl. 1 1997 62S 65S
6. I.P. Arrojo, M.O. Pareja, M.D. Orta, F.N. Luque, M.C. Lamas, and F.S. Gordo Detection of a healthy carrier of HCV with no evidence of antibodies for over four years Transfusion 43 2003 953 957
7. Committee for Proprietary Medicinal Products. Note for guidance on plasma derived medicinal products: the introduction of genomic amplification technology for plasma pool testing. European Agency for the Evaluation of Medicinal Products 1998, CPMP/BWP/390/97.
8. D. Forčić, R. Zgorelec, K. Branović, T. Košutić-Gulija, M. Šantak, and R. Mažuran Incidence of hepatitis C virus RNA in anti-HCV negative plasma pools in Croatia Transfus Apher Sci 24 2001 269 278
9. K. Branović, D. Forčić, T. Košutić- Gulija, M. Šantak, R. Zgorelec, and R. Mažuran Introduction of the gene amplification technique to decrease the risk of hepatitis C virus transmission by plasma products J Chromatogr A 852 1999 305 312
10. P. Chomczynski, and K. Mackey Single-step method of total RNA isolation by acid guanidine-phenol extraction Cell biology: a laboratory handbook 1998 Academic Press New York 221 224
11. S. Kwok, and R. Higuchi Avoiding false positives with PCR Nature 339 1989 237 238
12. M. Chudy, I. Hewlett, J. Saldanha, C. Bianco, A.J. Conrad, and T. Gierman Technical consideration for the performance of nucleic acid amplification technology (NAT) Biologicals 31 2003 153 159
13. E. Tabor The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1 Transfusion 39 1999 1160 1168
14. M.P. Busch Closing the windows on viral transmission by blood transfusion S.I. Stramer Blood safety in the new millennium 2001 American Association of Blood Banks Bethesda, MD 33 54
15. J. Saldanha, and P. Minor Incidence of hepatitis C virus RNA in anti-HCV-negative plasma pools and blood products Vox Sang 70 1996 232 234
16. W.K. Roth, M. Weber, S. Buhr, C. Drosten, W. Weichert, and W. Sireis Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe Transfusion 42 2002 862 868
17. G.B. Schreiber, M.P. Busch, S.H. Kleinman, and J.J. Korelitz The risk of transfusion-transmitted viral infection New Engl J Med 334 1996 1685 1690
18. H. Mine, H. Emura, M. Miyamoto, T. Tomono, K. Minegishi, and H. Murokawa High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan J Virol Meth 112 2003 145 151
19. World Health Organization Hepatitis C: global prevalence Wkly Epidemiol Rec 72 1997 341 348